Drug combination restores ability to signal for death of blood cancer cells

Acute myeloid leukaemia is tough to treat, with only about one-third of patients living five years after diagnosis – hence the importance of existing

Related Keywords

Christina Glytsou ,Iannis Aifantis ,Hermannm Biggs ,Xufeng Chen ,Grossman School Of Medicine ,Department Of Pathology ,Langone Health ,Rutgers University ,Perlmutter Cancer Center ,Cancer Discovery ,